ArticleFrontiers in oncology2024

Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.